Avricore Health Stock Performance
| AVCRF Stock | USD 0.05 0.01 24.21% |
The firm shows a Beta (market volatility) of -0.39, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Avricore Health are expected to decrease at a much lower rate. During the bear market, Avricore Health is likely to outperform the market. At this point, Avricore Health has a negative expected return of -0.9%. Please make sure to confirm Avricore Health's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Avricore Health performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Avricore Health has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 302.7 K | |
| Total Cashflows From Investing Activities | -140.4 K |
Avricore |
Avricore Health Relative Risk vs. Return Landscape
If you would invest 13.00 in Avricore Health on October 20, 2024 and sell it today you would lose (8.28) from holding Avricore Health or give up 63.69% of portfolio value over 90 days. Avricore Health is currently producing negative expected returns and takes up 11.9321% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Avricore, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Avricore Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Avricore Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Avricore Health, and traders can use it to determine the average amount a Avricore Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0751
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVCRF |
Estimated Market Risk
| 11.93 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.9 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Avricore Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Avricore Health by adding Avricore Health to a well-diversified portfolio.
Avricore Health Fundamentals Growth
Avricore Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Avricore Health, and Avricore Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Avricore Pink Sheet performance.
| Return On Equity | -0.38 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (0.95) % | |||
| Operating Margin | (1.23) % | |||
| Current Valuation | 21.9 M | |||
| Shares Outstanding | 98.62 M | |||
| Price To Book | 14.51 X | |||
| Price To Sales | 28.37 X | |||
| Revenue | 122.81 K | |||
| EBITDA | (1.65 M) | |||
| Cash And Equivalents | 1.44 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 40 K | |||
| Debt To Equity | 0.02 % | |||
| Book Value Per Share | 0.02 X | |||
| Cash Flow From Operations | (1.23 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 2.28 M | |||
About Avricore Health Performance
By analyzing Avricore Health's fundamental ratios, stakeholders can gain valuable insights into Avricore Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Avricore Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Avricore Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada. Avricore Health is traded on OTC Exchange in the United States.Things to note about Avricore Health performance evaluation
Checking the ongoing alerts about Avricore Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Avricore Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Avricore Health generated a negative expected return over the last 90 days | |
| Avricore Health has high historical volatility and very poor performance | |
| Avricore Health has some characteristics of a very speculative penny stock | |
| Avricore Health has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 122.81 K. Net Loss for the year was (1.71 M) with profit before overhead, payroll, taxes, and interest of 30.52 K. | |
| Avricore Health has accumulated about 1.44 M in cash with (1.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Avricore Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Avricore Health's stock is overvalued or undervalued compared to its peers.
- Examining Avricore Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Avricore Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Avricore Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Avricore Health's pink sheet. These opinions can provide insight into Avricore Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Avricore Pink Sheet analysis
When running Avricore Health's price analysis, check to measure Avricore Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avricore Health is operating at the current time. Most of Avricore Health's value examination focuses on studying past and present price action to predict the probability of Avricore Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avricore Health's price. Additionally, you may evaluate how the addition of Avricore Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |